These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6796932)

  • 1. Cholesterol, children, and heart disease: an analysis of alternatives.
    Berwick DM; Cretin S; Keeler E
    Pediatrics; 1981 Nov; 68(5):721-30. PubMed ID: 6796932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of work-site cholesterol screening and intervention programs.
    Wilson MG; Edmunson J; DeJoy DM
    J Occup Med; 1992 Jun; 34(6):642-9. PubMed ID: 1619496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of screening for hereditary hemochromatosis.
    Phatak PD; Guzman G; Woll JE; Robeson A; Phelps CE
    Arch Intern Med; 1994 Apr; 154(7):769-76. PubMed ID: 8147681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and health consequences of cholesterol screening for asymptomatic older Americans.
    Garber AM; Littenberg B; Sox HC; Wagner JL; Gluck M
    Arch Intern Med; 1991 Jun; 151(6):1089-95. PubMed ID: 1904212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of screening for celiac disease in the adult population.
    Shamir R; Hernell O; Leshno M
    Med Decis Making; 2006; 26(3):282-93. PubMed ID: 16751327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
    Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High participation rates are not necessary for cost-effective colorectal cancer screening.
    Howard K; Salkeld G; Irwig L; Adelstein BA
    J Med Screen; 2005; 12(2):96-102. PubMed ID: 15949121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of HIV screening in acute care settings.
    Owens DK; Nease RF; Harris RA
    Arch Intern Med; 1996 Feb; 156(4):394-404. PubMed ID: 8607724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy.
    Ess SM; Szucs TD
    Ital Heart J; 2001 Mar; 2(3):181-8. PubMed ID: 11305529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic screening for gastric cancer.
    Dan YY; So JB; Yeoh KG
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country.
    Brassard P; Steensma C; Cadieux L; Lands LC
    Pediatrics; 2006 Feb; 117(2):e148-56. PubMed ID: 16452324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic evaluation of screening for neuroblastoma].
    Lacour A; Chauvin F; Duru G; Philip T
    Rev Epidemiol Sante Publique; 1994; 42(1):24-33. PubMed ID: 8134663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
    Flaherman VJ; Porco TC; Marseille E; Royce SE
    Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
    Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
    Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA; Winston FK; Kallan MJ; Branas CC; Schwartz JS
    Ambul Pediatr; 2008; 8(1):58-65. PubMed ID: 18191783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for celiac disease in asymptomatic children with Down syndrome: cost-effectiveness of preventing lymphoma.
    Swigonski NL; Kuhlenschmidt HL; Bull MJ; Corkins MR; Downs SM
    Pediatrics; 2006 Aug; 118(2):594-602. PubMed ID: 16882812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of cholesterol-lowering drugs: a review of the evidence.
    Thorvik E; Aursnes I; Kristiansen IS; Waaler HT
    Wien Klin Wochenschr; 1996; 108(8):234-43. PubMed ID: 8686314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.